Galena Biopharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

LAKE OSWEGO, Oregon, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at the Lazard Capital Markets 9th Annual Healthcare Conference. The presentation will take place on Tuesday, November 13, 2012 at 2:30 p.m. EST at The Pierre Hotel in New York, NY.